Amyloids from the origin to the end of life

Add to your list(s) Download to your calendar using vCal

• Professor Roland Riek, ETH Zurich
• Wednesday 10 May 2017, 10:30-11:30
• Department of Chemistry, Cambridge, Unilever lecture theatre.

If you have a question about this talk, please contact ma505.

Protein aggregation is observed in many diseases including Alzheimer’s disease. These protein aggregates are termed amyloids. Amyloids are composed of pairs of tightly interacting, many-stranded, repetitive, inter-molecular beta-sheets termed the cross-beta-sheet structure. Because of this structure, amyloids can grow by recruitment of the same protein while their repeat can transform a weak activity into a potent one through cooperativity and avidity. Thus, an amyloid has the potential to replicate itself, and can be adaptive to its environment, yielding eventually cell-to-cell transmissibility, prion infectivity, and toxicity. Here, we discuss these structure-based properties within the context of Alzheimer’s disease and Parkinson’s disease from a structural perspective. In addition, we discuss a potential role of amyloids in the origin of life [1-3].

References

[1] J. Greenwald, M. Friedmann, Roland Riek, Angewandte Chemie 53, 11609 (2016).

[2] M. Wälti, F. Ravottie, H. Aral, C. Glabe, J. Wall, A. Bockmann, PO. Guntert, B. Meier, R. Riek, PNAS 113 , E4976 (2016).

[3] R. Riek and D. Eisenberg, Nature 539, 227 (2016).

This talk is part of the Biophysical Seminars series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• Biophysical Seminar Series 2016/17
• Biophysical Seminars
• Department of Chemistry
• Department of Chemistry, Cambridge, Unilever lecture theatre
• Featured lists
• School of Physical Sciences

Note that ex-directory lists are not shown.